Because PCOS is closely associated with endocrine and metabolic disorders, to investigate the effect of omega-3 PUFAs on metabolism and endocrine function, we established a PCOS model (Fig. 1A) and assessed serum hormone levels, glucose homeostasis and insulin sensitivity in diverse groups (Fig. 1). Here, INS is linked to metabolic disease.